World Lifestyle Archives | Page 17 of 417 | Be Korea-savvy

Archive by category World Lifestyle

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

Music Licensing, Inc. (OTC: SONG) Announces Acquisition of Royalty Rights to “Thank God I Got It” by Desiigner, Bolstering Its Diverse and Star-Studded Portfolio

NAPLES, Fla., Sept. 03, 2024 (GLOBE NEWSWIRE) – Music Licensing, Inc. (OTC: SONG), a leading entity in the music industry, is excited to announce the acquisition of the royalty rights to “Thank God I Got It” by the renowned artist Desiigner. This acquisition underscores Music Licensing, Inc.’s commitment to diversifying its portfolio with high-quality, revenue-generating [...]

Constellation Brands Updates Fiscal 2025 Outlook

Constellation Brands Updates Fiscal 2025 Outlook

Updates reported EPS guidance to $3.05 – $7.92 and raises lower-end of comparable EPS guidance to $13.60 – $13.80, affirming double-digit comparable EPS growth expectation (1) Updates Enterprise net sales growth to 4% – 6%, reported operating income decline to (68)% – (36)% including an expected Wine and Spirits goodwill impairment loss of approximately $1.5 – [...]

Modelo Teams Up with Reggie Bush to Recruit Full-Time College Football Fans

Modelo Teams Up with Reggie Bush to Recruit Full-Time College Football Fans

Modelo, the Official Beer Sponsor of the College Football Playoff, is recruiting the most dedicated fans to win a trip to the 2025 CFP National Championship CHICAGO, Sept. 03, 2024 (Korea Bizwire) – As the College Football Playoff (CFP) expands to 12 teams, there’s never been a more exciting time to be a fan. To [...]

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies. SALT LAKE CITY, Sept. 03, 2024 (Korea Bizwire) – Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to [...]

Deriv Celebrates 25th Anniversary with “UK’s Best Workplaces in Financial Services & Insurance™” Win

Deriv Celebrates 25th Anniversary with “UK’s Best Workplaces in Financial Services & Insurance™” Win

UK office has also received a renewal for its Great Place to Work® certifications alongside six other Deriv offices Celebrates 25 years of building a positive workplace culture LONDON, Sept. 03, 2024 (Korea Bizwire) – Deriv, a leading online trading platform celebrating 25 years of innovation and service, has been recognised as one of the “UK’s [...]

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

Boehringer Ingelheim acquires Saiba Animal Health, adding innovative technology platform to its pet therapeutics R&D portfolio

INGELHEIM, Germany, September 03, 2024 – Boehringer Ingelheim today said it has acquired Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category. As life [...]

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval on track for the end of 2024 U.S. commercial launch, expected at the beginning of 2025, fully funded with over €85 million in new capital [...]

GOTS combatting greenwashing with #BehindTheSeams campaign that educates consumers about sustainable textiles

GOTS combatting greenwashing with #BehindTheSeams campaign that educates consumers about sustainable textiles

More than 290 brands worldwide participating; Fashion, mattresses and more among giveaways; Manufacturers, brands and consumers urged to support organic in-conversion fibres through the Organic Cotton Accelerator’s Farm Programme Stuttgart, Germany, Sept. 02, 2024 (Korea Bizwire) – For the second year running, Global Standard is taking consumers #BehindTheSeams this September, highlighting the sustainable and social qualities of [...]

CORRECTION: The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond

CORRECTION: The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond

The GVN MPOX Action Committee is poised to mobilize resources and catalyze efforts in the urgent global call to action TAMPA, Fla., Sept. 02, 2024 (Korea Bizwire) – A correction has been issued for the release disseminated on August 16th. Sten Vermund’s full title was corrected to Sten Vermund, MD, PhD, GVN President and Professor [...]

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer

Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer

Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt disease SAN DIEGO, Sept. 01, 2024 (Korea Bizwire) – Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel [...]